Skip to main content

Our team believes in doing things the right way, and we’re fortunate to be led by people with a proven track record of therapeutic development through commercialization in diseases with high unmet needs.

Amylyx leadership team smiling in front of the Amylyx sign. The sign reads, "Rooted in Connection."

Executive Team

Amylyx' Chief Human Resources Officer, Linda Arsenault. READ BIO

Linda A. Arsenault

Chief Human Resources Officer

READ BIO
Amylyx' Co-Founder and Co-CEO, Josh Cohen. READ BIO

Josh Cohen

Co-Chief Executive Officer & Co-Founder

READ BIO
Headshot of James M. Frates READ BIO

James M. Frates

Chief Financial Officer

READ BIO
Headshot of Tom Holmes READ BIO

Tom Holmes

Chief Technical Operations Officer

READ BIO
Amylyx' Co-Founder and Co-CEO, Justin Klee. READ BIO

Justin Klee

Co-Chief Executive Officer & Co-Founder

READ BIO
Amylyx' Chief Legal Office, Gina Mazzariello. READ BIO

Gina M. Mazzariello

Chief Legal Officer & General Counsel

READ BIO
Amylyx' Chief Commercial Officer, Dan Monahan. READ BIO

Dan Monahan

Chief Commercial Officer

READ BIO

Board of Directors

Amylyx’ directors bring decades of experience in innovative drug development, global commercialization, and company building for rare disease R&D through launch.

Key Advisors

Headshot of Rudolph Tanzi READ BIO

Rudolph Tanzi, PhD

Founding Chair of the Amylyx Scientific Advisory Board

READ BIO

Rooted in Connection

Our work, our motivation, and the core values that guide us are deeply interwoven. Learn more about Amylyx’ path to progress as we usher in a new era for treating diseases with high unmet needs.